Minimal invasive treatment of uterine myoma: Laparoscopic radiofrequency myolysis.
- Author:
Jeong Jae LEE
1
;
Jung Bum CHOI
;
Eun Hee PARK
;
Mi Kyung KIM
;
Im Soon LEE
Author Information
1. Department of Obstetrics and Gynecology, College of Medicine, Soonchunhyang University, Seoul, Korea. jjlee@hosp.sch.ac.kr
- Publication Type:Original Article
- Keywords:
Radiofrequency;
Myolysis;
Myoma uteri
- MeSH:
Hot Temperature;
Humans;
Laparoscopy;
Leiomyoma*;
Myoma;
Postoperative Period;
Preoperative Period;
Quality of Life;
Ultrasonography
- From:Korean Journal of Obstetrics and Gynecology
2006;49(6):1212-1218
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: To evaluate the feasibility, efficacy and safety of minimal invasive treatment of uterine myoma with laparoscopic radiofrequency (RF) myolysis. METHODS: 69 patients with symptomatic uterine myomas underwent laparoscopy assisted RF myolysis. The accurate targeting and thermal intensity during the procedure were guided by trans-vaginal ultrasound. The measurement of myoma volume and UFS-QOL (Uterine fibroid symptom-quality of life) were obtained once at preoperative period and four times at postoperative period of one week, 1, 3, 6 months. Wilcoxon signed rank test (SPSS 7.5) was used to compare the volume changes of myoma. A significant level of p<0.05 was considered. RESULTS: 107 fibroids were treated with RF myolysis. The mean duration of RF procedure was 15.2+/-18.5 minutes. Mean preoperative volume of treated fibroids was 75.7 cm3 (range: 8.2-367.7) and the mean volume decrease was 12.1+/-10.2%, 32.3+/-40.2%, 48.3+/-33.6%, 53.5+/-18.1% at one week, 1, 3, 6 months. Fifty eight patients had improved symptom severity with UFS-QOL score: symptom severity score 30.8+/-8.2 (mean+/-S.D.), quality of life score 20.3+/-9.2 after RF myolysis. There were 3 cases of RF heat related complication. CONCLUSION: Early experience of laparoscopy assisted RF myolysis in the treatment of uterine fibroids shows that the method is safe and effective under the guidance of trans-vaginal sonification.
